Interestingly, several clinical studies involving patients with CKD stages 3–4 [12] and 2–4 [13], along with patients undergoing hemodialysis [14], have demonstrated an association between FGF23 and anemia. This evidence concerns the gene FGF23 and anemia (phenotype).